Início › Síndromes Mielodisplásicas › Louisiana

Ensaios clínicos de Síndromes Mielodisplásicas em Louisiana

5 estudos para Síndromes Mielodisplásicas estão buscando participantes em locais em Louisiana.

Texto oficial do estudo (Inglês)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

LSU Health Baton Rouge-North Clinic, Baton Rouge
Our Lady of the Lake Physician Group, Baton Rouge
Our Lady of The Lake, Baton Rouge

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT05564390

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

LSU Health Baton Rouge-North Clinic, Baton Rouge
Our Lady of the Lake Physician Group, Baton Rouge
Our Lady of The Lake, Baton Rouge

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT06577441

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Epic Medical Research, Monroe
Epic Medical Research - Shreveport, Shreveport

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT07422480

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Ochsner Medical Center Jefferson, New Orleans

RecrutandoFase 1/2

Até 22 anos · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT04726241

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, New Orleans

RecrutandoEstudo observacional

Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774

Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.